Trial intelligence / Profile preview

Buscopan injection vs anisodamine for acute gastrointestinal spasm pain

CTR20132677Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hyoscine butylbromide in Abdominal discomfort, sponsored by Boehringer Ingelheim. Started Mar 2014; status: completed.

02

Drugs

hyoscine butylbromide
03

Conditions

Abdominal discomfort

Beyond the preview

Go deeper on CTR20132677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call